TCIM
NAGE
TIAA CREF Investment Management’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $206K | Hold |
49,224
| – | – | ﹤0.01% | 2879 |
|
|
2018
Q4 | $169K | Hold |
49,224
| – | – | ﹤0.01% | 2904 |
|
|
2018
Q3 | $211K | Sell |
49,224
-9,802
| -17% | -$42K | ﹤0.01% | 2968 |
|
|
2018
Q2 | $219K | Buy |
+59,026
| New | +$219K | ﹤0.01% | 3020 |
|
|
2017
Q2 | – | Sell |
-81,255
| Closed | -$219K | – | 3185 |
|
|
2017
Q1 | $219K | Sell |
81,255
-2,794
| -3% | -$7.53K | ﹤0.01% | 2978 |
|
|
2016
Q4 | $278K | Buy |
84,049
+9
| +0% | +$30 | ﹤0.01% | 2990 |
|
|
2016
Q3 | $250 | Hold |
84,040
| – | – | ﹤0.01% | 3025 |
|
|
2016
Q2 | $348K | Buy |
+84,040
| New | +$348K | ﹤0.01% | 2997 |
|